SEC Form 4 research
| Issuer | RECURSION PHARMACEUTICALS, INC. |
|---|---|
| Tickers | RXRX |
| Reporting owners | 37 |
| Officers and directors | 12 |
| Last public filing | 2026-10-07 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-07 | 2026-10-06 | Borgeson Blake | S | 50,000 | $4.84 | Not reported |
| 2026-10-07 | 2026-10-06 | HERSHBERG ROBERT | S | 25,000 | $5 | Not reported |
| 2026-10-02 | 2026-10-01 | Dar Zavain | A | 4,607 | $0 | Not reported |
| 2026-10-02 | 2026-10-01 | Li Dean Y | A | 3,378 | $0 | Not reported |
| 2026-09-10 | 2026-09-08 | Khan Najat | S | 22,408 | $3.52 | Not reported |
| 2026-09-02 | 2026-09-01 | Borgeson Blake | S | 30,000 | $3.34 | Not reported |
| 2026-08-06 | 2026-08-04 | Borgeson Blake | S | 30,000 | $3.25 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.